IMUNOVIR
Identification of Imunovir
| No description |
Google image searchProduct monograph
Active ingredient
inosine pranobex, 500 MG
DIN: 02240713
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: KORA HEALTHCARE
Date: 07-MAY-2013
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AX — Other antivirals (ATC, ATC/DDD)
- J05AX05 — INOSINE PRANOBEX (ATC/DDD)
Reference brand drug: Imunovir
Pharmaceutical standard: MFR
